Search Results 681-690 of 19283 for Myocardium
- Myocardial infarction within 6 months prior to day 1 of treatment - Clinically significant arrhythmias or conduction block (premature atrial contractions ...
Myocardial infarction less than 6 months before start of study drug 4. Anti-arrhythmic therapy (beta blockers are permitted) 5. Any unstable ischemic ...
Myocardial strain is a measure of how the heart muscle functions when it contracts and relaxes to pump blood. The study used the resources of the Rochester ...
Clinically significant cardiovascular diseases, including acute myocardial infarction, unstable angina, coronary artery bypass surgery within 6 months ...
... myocardial infarction within 3 months prior to initiation of treatment, unstable arrhythmias, or unstable angina given the higher risks associated with ...
Subjects with recent history (within 1 year of Day 1) of significant atherosclerotic cardiovascular disease (ASCVD; myocardial infarction, unstable angina ...
Stroke (including TIA), myocardial infarction, or other ischemic event within 6 mo before randomization. Gastrointestinal (GI) disorders including those ...
Uncontrolled, current significant cardiac disease including unstable angina, acute myocardial infarction within six months prior to randomization ...
... myocardial infarction, clinically significant heart failure, cerebrovascular disease, venous thromboembolic events, clinically significant arrhythmias) 20 ...
The patient has active heart disease including myocardial infarction within previous 3 months, symptomatic coronary artery disease, arrhythmias not ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.